Such integrated studies evaluating in silico, in vitro, and in vivo properties characterizing the drug characteristics of anti-VEGF agents have the potential to expand our understanding of important translational properties of these agents that are currently used for the treatment of retinal diseases. Here, VEGFA is linked to Abnormal retinal morphology.